MMIT et Evaluate acquièrent Panalgo pour apporter confiance et célérité à l'analyse et à la prise de décision dans le domaine pharmaceutique itespresso.fr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itespresso.fr Daily Mail and Mail on Sunday newspapers.
(1)
Panalgo s IHD software to be used by the EMA to rapidly answer questions around drug safety and efficacy and better understand real-world medication use
BOSTON, Jan. 6, 2021 /PRNewswire/ Panalgo, a leading healthcare analytics company, today announced that its Instant Health Data (IHD) platform will be used by the European Medicines Agency (EMA) to facilitate the analysis of real-world data.
EMA will use IHD to undertake rapid analyses of Electronic Healthcare Data (EHDs) accessible in-house (currently data from the UK, France, and Germany) to more quickly examine drug utilization, assess safety/efficacy, understand how treatments perform in real-world settings, and support public health efforts in the European Union (EU).